North American Group for New Cancer Treatments
North American Star Consortium
['FUNDING_OTHER'] · UNIVERSITY HEALTH NETWORK · NIH-11074688
This group brings together top cancer centers to find new ways to treat cancer through early stage clinical trials.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY HEALTH NETWORK (nih funded) |
| Locations | 1 site (TORONTO, CANADA) |
| Trial ID | NIH-11074688 on ClinicalTrials.gov |
What this research studies
This collaborative group brings together leading cancer centers across North America to discover and test new treatments for various cancers. Our goal is to find promising anti-cancer agents and understand how they work in the body, including identifying important biological markers. We conduct early-stage clinical trials, offering patients access to innovative therapies that are still in development. The consortium also focuses on ensuring diverse patient participation and advancing the field through scientific research.
Who could benefit from this research
Good fit: Patients with various types of cancer who are seeking early-stage experimental treatments may be ideal candidates.
Not a fit: Patients who are not eligible for early-phase clinical trials or whose cancer type is not currently being studied may not receive direct benefit.
Why it matters
Potential benefit: If successful, this work could lead to new and more effective anti-cancer treatments for patients.
How similar studies have performed: The consortium has a track record of activating numerous early-phase clinical trials and successfully enrolling patients in previous iterations.
Where this research is happening
TORONTO, CANADA
- UNIVERSITY HEALTH NETWORK — TORONTO, CANADA (ACTIVE)
Researchers
- Principal investigator: BEDARD, PHILIPPE — UNIVERSITY HEALTH NETWORK
- Study coordinator: BEDARD, PHILIPPE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anti-Cancer Agents, Cancer Center, Cancer Drug, Cancer Therapy Evaluation Program, Cancers